Pharmacogenetics in the High Street

During development of a new drug molecule, a wealth of information is collected about the new medicine, some of this will end up on the drug label.  It has been estimated that up to 40% of the drug label consists of data of a clinical pharmacology nature; often this may include pharmacogenomic (Pgx) information.  Pgx […]

Continue reading